| Primary |
| Cerebrovascular Accident Prophylaxis |
28.4% |
| Hypertension |
17.6% |
| Transient Ischaemic Attack |
15.6% |
| Cerebrovascular Accident |
9.3% |
| Blood Cholesterol Increased |
6.3% |
| Prophylaxis |
4.5% |
| Diabetes Mellitus |
3.2% |
| Depression |
1.7% |
| Hypothyroidism |
1.6% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Supplementation Therapy |
1.5% |
| Asthma |
1.2% |
| Cardiac Disorder |
1.1% |
| Pain |
1.1% |
| Anticoagulant Therapy |
1.0% |
| Osteoporosis |
1.0% |
| Type 2 Diabetes Mellitus |
0.9% |
| Blood Pressure Increased |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Osteoarthritis |
0.8% |
|
| Headache |
23.5% |
| Vomiting |
12.6% |
| Cerebrovascular Accident |
11.5% |
| Transient Ischaemic Attack |
8.9% |
| Nausea |
7.5% |
| Pain In Extremity |
4.3% |
| Cerebral Haemorrhage |
3.1% |
| Gastrointestinal Haemorrhage |
2.8% |
| Rash |
2.8% |
| Myocardial Infarction |
2.6% |
| Weight Decreased |
2.5% |
| Diarrhoea |
2.4% |
| Haemorrhage |
2.4% |
| Death |
2.2% |
| Renal Failure |
2.2% |
| Contusion |
1.8% |
| Haemorrhage Intracranial |
1.8% |
| Subdural Haematoma |
1.8% |
| Hypertension |
1.7% |
| Cerebral Infarction |
1.4% |
|
| Secondary |
| Cerebrovascular Accident Prophylaxis |
19.4% |
| Hypertension |
15.7% |
| Transient Ischaemic Attack |
14.0% |
| Cerebrovascular Accident |
9.6% |
| Gastrooesophageal Reflux Disease |
4.2% |
| Drug Use For Unknown Indication |
4.1% |
| Hypersensitivity |
3.7% |
| Diabetes Mellitus |
3.6% |
| Asthma |
3.5% |
| Prophylaxis |
3.1% |
| Blood Cholesterol Increased |
2.9% |
| Depression |
2.9% |
| Migraine |
2.4% |
| Product Used For Unknown Indication |
1.8% |
| Carotid Artery Occlusion |
1.7% |
| Atrial Fibrillation |
1.6% |
| Chest Pain |
1.6% |
| Anxiety |
1.4% |
| Fluid Retention |
1.4% |
| Muscle Spasms |
1.4% |
|
| Headache |
15.0% |
| Vomiting |
15.0% |
| Memory Impairment |
8.3% |
| Cerebrovascular Accident |
6.3% |
| Sepsis |
5.8% |
| Transient Ischaemic Attack |
5.3% |
| Pain In Extremity |
4.4% |
| Myocardial Infarction |
3.9% |
| Renal Failure |
3.9% |
| Thrombocytopenia |
3.9% |
| Renal Disorder |
3.4% |
| Syncope |
3.4% |
| Cerebral Haemorrhage |
2.9% |
| Incorrect Dose Administered |
2.9% |
| Laryngeal Oedema |
2.9% |
| Urinary Tract Infection |
2.9% |
| Dyspnoea |
2.4% |
| Gastrointestinal Haemorrhage |
2.4% |
| Hypotension |
2.4% |
| Renal Failure Chronic |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.3% |
| Drug Use For Unknown Indication |
21.2% |
| Hypertension |
10.7% |
| Pain |
3.8% |
| Osteoporosis |
3.5% |
| Diabetes Mellitus |
3.1% |
| Prophylaxis |
3.0% |
| Rheumatoid Arthritis |
3.0% |
| Blood Cholesterol Increased |
2.8% |
| Cerebrovascular Accident |
2.8% |
| Anticoagulant Therapy |
2.5% |
| Depression |
2.3% |
| Type 2 Diabetes Mellitus |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Cerebrovascular Accident Prophylaxis |
2.0% |
| Blood Pressure |
1.9% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Transient Ischaemic Attack |
1.5% |
| Multiple Myeloma |
1.5% |
| Arthritis |
1.4% |
|
| Transient Ischaemic Attack |
14.1% |
| Vomiting |
11.7% |
| Weight Decreased |
9.5% |
| Cerebrovascular Accident |
8.1% |
| Weight Increased |
7.0% |
| Somnolence |
4.6% |
| Urinary Tract Infection |
4.0% |
| Drug Ineffective |
3.7% |
| Flushing |
3.7% |
| Unresponsive To Stimuli |
3.7% |
| Death |
3.5% |
| Pain |
3.1% |
| Respiratory Failure |
3.1% |
| Muscular Weakness |
2.9% |
| Nausea |
2.9% |
| Pain In Extremity |
2.9% |
| Pneumonia |
2.9% |
| Pruritus |
2.9% |
| Renal Failure Acute |
2.9% |
| Tremor |
2.9% |
|
| Interacting |
|
| Drug Ineffective |
50.0% |
| Drug Interaction |
50.0% |
|
